Miika J. Ahdesmaki
Oncology R&D, 1 Francis Crick Avenue
Cambridge, ENG CB20RE, United Kingdom
Cambridge, ENG CB20RE, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Genome-wide CRISPR screens identify the YAP/TEAD axis as a driver of persister cells in EGFR mutant lung cancer.
Journal: Communications biology
Published: January 27, 2023
Drug-gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP Inhibition.
Journal: Cancer research communications
Published: March 17, 2022
Hydroxymethylation profile of cell-free DNA is a biomarker for early colorectal cancer.
Journal: Scientific reports
Published: November 15, 2021
Knowledge graph-based recommendation framework identifies drivers of resistance in EGFR mutant non-small cell lung cancer.
Journal: Nature communications
Published: August 25, 2021
Improved PDX and CDX Data Processing-Letter.
Journal: Molecular cancer research : MCR
Published: May 23, 2018
Correction: Altered regulation and expression of genes by BET family of proteins in COPD patients.
Journal: PloS one
Published: April 14, 2017
Disambiguate: An open-source application for disambiguating two species in next generation sequencing data from grafted samples.
Journal: F1000Research
Published: January 23, 2017
Prioritisation of structural variant calls in cancer genomes.
Journal: PeerJ
Published: November 30, 2016
Altered regulation and expression of genes by BET family of proteins in COPD patients.
Journal: PloS one
Published: August 31, 2016
Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery.
Journal: Cancer immunology research
Published: May 20, 2016
AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies.
Journal: Molecular cancer therapeutics
Published: March 14, 2016
Last Updated: 09/26/2026